Company Overview
- Headquarters
- 225 Franklin Street, Boston MA
- Website
- palvellatx.com
- re****@pieris.com
- Phone
- (857) 246-8998
- Employees
- 55
- Founded in
- 2015
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:PIR
- NAICS Code
-
NAICS Code 32541 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 325414 Companies
- SIC Code
-
SIC Code 283 CompaniesSIC Code 28 Companies
Financials & Stats
Revenue
$46B
Who is Pieris Pharmaceuticals
Pieris Pharmaceuticals is a biotechnology company based in Boston, Massachusetts. Pieris develops 4-1BB bispecifics immuno-oncology assets. The company's business model involves partnering with pharmaceutical companies for development, regulatory, and sales-based milestones, as well as potential sales royalties. Pieris targets pharmaceutical companies and investors seeking innovative oncology treatments. Its geographic coverage is global, and sales channels include partnerships. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS. Pieris Pharmaceuticals www.pieris.com
Company Leadership
Pieris Pharmaceuticals Industry Tags
Pieris Pharmaceuticals Tech Stack
Companies Similar to Pieris Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Pieris Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 46M | 143 | Watertown, MA | 2016 | |
| 45M | 17 | Johannesburg, CA | 1997 | |
| 40M | 686 | Danvers, MA | 1999 | |
| 39M | 4 | Raynham, MA | 2016 | |
| 39M | 138 | Rockville, MD | 1999 |